1. Home
  2. GSUN vs PPCB Comparison

GSUN vs PPCB Comparison

Compare GSUN & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

N/A

Current Price

$0.23

Market Cap

2.7M

Sector

Real Estate

ML Signal

N/A

Logo Propanc Biopharma Inc.

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.85

Market Cap

2.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
GSUN
PPCB
Founded
1997
2007
Country
China
Australia
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.6M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
GSUN
PPCB
Price
$0.23
$0.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.2M
3.4M
Earning Date
02-13-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.06
52 Week High
$3.31
$6.79

Technical Indicators

Market Signals
Indicator
GSUN
PPCB
Relative Strength Index (RSI) 41.29 39.84
Support Level $0.17 $0.15
Resistance Level $0.55 $1.44
Average True Range (ATR) 0.07 0.28
MACD -0.00 -0.04
Stochastic Oscillator 9.78 0.21

Price Performance

Historical Comparison
GSUN
PPCB

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: